Göran Albert Ando
Chairman chez EYEPOINT PHARMACEUTICALS, INC.
Fortune : 168 461 $ au 31/03/2024
Provenance du réseau au premier degré de Göran Albert Ando
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.
104
| Extinct | Pharmaceuticals: Major | 104 |
| Public Company | Pharmaceuticals: Major | 59 | |
EDB Investments Pte Ltd.
 EDB Investments Pte Ltd. Investment ManagersFinance EDB Investments Pte Ltd (EDB Investments) is a Venture Capital firm founded in 1991. The firm is headquartered in Singapore.
32
| Subsidiary | Investment Managers | 32 |
Pharmacia & Upjohn, Inc.
29
| Extinct | Pharmaceuticals: Major | 29 |
| Public Company | Pharmaceuticals: Major | 25 | |
| Public Company | Biotechnology | 19 | |
| Holding Company | Miscellaneous Commercial Services | 15 | |
CBio Ltd.
 CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.
15
| Extinct | Biotechnology | 15 |
14
| Public Company | Medical Specialties | 14 |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore.
13
| Holding Company | Biotechnology | 13 |
The International Centre for Missing & Exploited Children
 The International Centre for Missing & Exploited Children Services to the Health IndustryHealth Services The International Centre for Missing & Exploited Children is an organization that focuses on finding missing children and protecting children from exploitation worldwide. The non-profit company is based in Alexandria, VA and the CEO of the company is Paul Shapiro. The company's work involves powering the search for missing children and implementing measures to safeguard children from harm.
12
| Non-Profit Organization | Services to the Health Industry | 12 |
Nouscom Srl
10
| Subsidiary | Miscellaneous Commercial Services | 10 |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Pharmacia AB
10
| Extinct | Pharmaceuticals: Major | 10 |
9
| Public Company | Pharmaceuticals: Major | 9 |
| Extinct | Biotechnology | 9 | |
Inion Oy
 Inion Oy BiotechnologyHealth Technology Inion Oy is a medical devices company focused on the development and commercialization of innovative biodegradable and bioactive implants for applications in Spine and Specialty Orthopedics applications. By targeting key strategic markets in the USA and select territories in the rest of the world, Inion has built a product portfolio sold through a dedicated network of specialist distributors. Inion's products include biodegradable plates, screws, pins and membranes, which are used to enhance the healing of bone or soft tissue injuries, such as those caused by trauma or by reconstructive surgery. Inion's core expertise is in the design and manufacture of implants from its proprietary Inion Optima™ family of biomaterials, which enables the Company to develop medical implants with properties tailored for specific surgical applications, in terms of strength, flexibility and rate of degradation. Incorporated in 2000, Inion has offices in the UK and USA, and its head office, R&D and manufacturing facilities are in Tampere, Finland.
6
| Extinct | Biotechnology | 6 |
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom.
6
| Subsidiary | Medical Distributors | 6 |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom.
5
| Extinct | Biotechnology | 5 |
RAND Health
5
| Subsidiary | 5 | |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Essex Woodlands Health Ventures UK Ltd.
2
| Subsidiary | Investment Managers | 2 |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services.
2
| College/University | Other Consumer Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Göran Albert Ando via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Zeneus Pharma Ltd.
 Zeneus Pharma Ltd. Medical DistributorsDistribution Services Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK. | Medical Distributors | Founder General Counsel | |
| The American University of Rome | College/University | Doctorate Degree Corporate Officer/Principal | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member Director/Board Member General Counsel Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
| National University of Singapore | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Imperial College London | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Aberdeen | College/University | Undergraduate Degree Doctorate Degree | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
| OPTOS PLC | Medical Specialties | Director/Board Member Chairman | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| University of Zurich | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal President Corporate Officer/Principal | |
| European Round Table of Industrialists | Corporate Officer/Principal Corporate Officer/Principal | ||
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Okairos AG
 Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal Director/Board Member | |
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Human Resources Officer President | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
EUSA Pharma SAS
 EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | Biotechnology | Chairman Chief Executive Officer | |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| ADDLIFE AB | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| Pdi, Inc. (United States) | Chief Executive Officer Chief Tech/Sci/R&D Officer | ||
EUSA Pharma Holdco 1 (UK) Ltd.
 EUSA Pharma Holdco 1 (UK) Ltd. Medical DistributorsDistribution Services Founded in 2015, EUSA Pharma Holdco 1 (UK) Ltd. is a holding British company that operates subsidiaries which wholesale pharmaceutical products. The private company is based in Hempstead, UK. | Medical Distributors | Director/Board Member Director/Board Member | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 23 |
| Royaume-Uni | 11 |
| Suisse | 6 |
| Suède | 6 |
| France | 4 |
Sectorielle
| Health Technology | 31 |
| Consumer Services | 11 |
| Health Services | 4 |
| Distribution Services | 3 |
| Finance | 3 |
Opérationnelle
| Director/Board Member | 630 |
| Corporate Officer/Principal | 216 |
| Chairman | 168 |
| Independent Dir/Board Member | 165 |
| Chief Executive Officer | 100 |
Relations les plus connectées
| Insiders | |
|---|---|
| Franz Humer | 45 |
| Scott Rocklage | 32 |
| Jean-Paul Prieels | 32 |
| Sten Gunnar Otto Skolling | 32 |
| Eva Nilsagård | 30 |
| Wendy DiCicco | 30 |
| Birgit Stattin Norinder | 29 |
| Fred Hassan | 29 |
| William W. Crouse | 29 |
| Michael W. Ferro | 29 |
| Steven Holtzman | 28 |
| David Guyer | 27 |
| William Burns | 27 |
| Thomas Paul Koestler | 26 |
| Peter Allen | 26 |
- Bourse
- Insiders
- Göran Albert Ando
- Connexions Sociétés
